LINDSEY SELBY: Open Payments
NPI 1215464482 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $66 |
| PFIZER INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Chiesi USA, Inc. | 1 | $16 |
Products named: VYNDAQEL, EVKEEZA, FABRAZYME, CAMZYOS, FUROSCIX, THORATEC HEARTMATE 3, CLEVIPREX.
Industry payments across PA — which companies pay providers there.
